✦ LIBER ✦

NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer

✍ Scribed by Johanna Hilli; Liisa Sailas; Sirkku Jyrkkiö; Seppo Pyrhönen; Kari Laine

Publisher: Springer
Year: 2010
Tongue: English
Weight: 388 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1426-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The significance of delay in relation to

The significance of delay in relation to prognosis of patients with primary operable breast cancer

✍ Guy F. Robbins; Irvin Bross 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Progesterone receptor activity and relap

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy

✍ J. M. M. Raemaekers; L. V. A. M. Beex; G. F. F. M. Pieters; A. G. H. Smals; Th. 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 806 KB

The activity of phosphohexose isomerase

The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease

✍ Irene Mitchell; N. Deshpande; Rosemary Millis; R. D. Rubens 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 269 KB

Depression of serum melatonin in patient

Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism

✍ Christian Bartsch; Hella Bartsch; Otto Bellmann; Theodor H. Lippert 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Disease-free interval and estrogen recep

Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

✍ J. M. M. Raemaekers; L. V. A. M. Beex; A. J. M. Koenders; G. F. F. M. Pieters; A 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 535 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b